Valcrest Pharmaceuticals' Unattributed Round

Valcrest Pharmaceuticals raised a round of funding on March 27, 2015.

Valcrest Pharmaceuticals specializes in the development and commercialization of novel pharmaceutical products to address the special needs of patients with ultra-rare orphan diseases. The founding me…

Articles about Valcrest Pharmaceuticals' Unattributed Round: